2018 News Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
Ra Pharmaceuticals to Present at the RBC Capital Markets 2018 Global Healthcare Conference

Read More

Ra Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Read More

Ra Pharmaceuticals Announces Proposed Public Offering of Common Stock

Read More

Ra Pharmaceuticals Announces Completion of Dosing in Phase 2 Program of RA101495 SC in Paroxysmal Nocturnal Hemoglobinuria

Read More

Ra Pharmaceuticals Initiates Dosing in Phase 1b Pharmacokinetic Study Evaluating RA101495 SC in Patients with Renal Impairment

Read More